Precipio Inc

PRPO

Company Profile

  • Business description

    Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents, and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.

  • Contact

    4 Science Park
    New HavenCT06511
    USA

    T: +1 203 787-7888

    E: [email protected]

    https://www.precipiodx.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Diagnostics & Research

    Fiscal Year End

    31 December 2025

    Employees

    60

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,235.8060.700.74%
CAC 407,536.2633.480.45%
DAX 4022,242.45177.940.81%
Dow JONES (US)40,113.5020.100.05%
FTSE 1008,415.257.810.09%
HKSE21,959.1421.60-0.10%
NASDAQ17,382.94216.901.26%
Nikkei 22535,887.89182.150.51%
NZX 50 Index12,121.14103.300.86%
S&P 5005,525.2140.440.74%
S&P/ASX 2008,029.6061.400.77%
SSE Composite Index3,295.320.260.01%

Market Movers